Community Oncology Alliance calls on Congress to speed cancer care and cut coverage barriers

The Community Oncology Alliance urged lawmakers to reform health coverage so patients with cancer can afford treatment, avoid delays, and stay with in-network community oncologists. The group’s Senate Finance response presses for stronger insurer accountability and protections for independent practices.

Why it matters: - Patients with cancer can face delays, surprise costs, and network gaps that interrupt treatment when insurance coverage does not match real-world care needs. - COA says reforms should be judged by whether patients can actually get timely, affordable care from the oncology team they already know. - The group argues that protecting independent community oncology matters because many patients receive treatment close to home.

What happened: - The Community Oncology Alliance submitted comments to Senate Finance Committee Ranking Member Ron Wyden’s request for information, “Health Coverage That Works for Everyone.” - COA urged Congress to strengthen patient protections, reduce treatment delays, and preserve access to independent community oncology. - Chief medical officer Johnetta Blakely, MD, MS, MMHC, said coverage is not meaningful if patients cannot afford it or cannot find an oncologist in their network. - Dr. Blakely said patients should not have to wait while insurers second-guess treating physicians or discover after treatment that claims will not be paid.

The details: - COA said lower premiums do little if patients still face unaffordable deductibles, high coinsurance, or networks that exclude their oncology team. - COA urged Congress to make cancer treatment affordable by replacing percentage-based coinsurance for guideline-supported active treatment with predictable cost-sharing or no cost-sharing for designated high-value services. - COA also called for out-of-pocket limits that reflect families’ financial resources. - COA recommended prohibiting prior authorization for FDA-approved, guideline-supported cancer treatment ordered by an in-network oncologist, including appropriate guideline-supported off-label uses. - COA called for qualified oncology review of adverse decisions and a ban on denials based solely on artificial intelligence or algorithms. - COA urged stronger oncology networks and protections against mid-treatment changes in insurance networks, drug coverage, or pharmacy requirements. - COA called for clear denial explanations, timely independent appeals, and enforceable payment deadlines. - COA recommended prohibiting steering to insurer-owned practices and pharmacies based on ownership rather than patient interests. - COA also called for disclosure of financial transfers among affiliated companies and an end to discriminatory payment practices that pressure independent practices to sell. - COA said it supports the RFI’s focus on affordability and insurer accountability. - COA opposed a single-payer system and Medicare buy-in proposals. - The letter warned against building a federal public option on Medicare physician payment rates that COA views as inadequate or on mandatory physician participation.

Between the lines: - COA is pushing Congress toward insurance rules that prioritize access and clinical judgment over utilization controls. - The group’s push against insurer-owned steering and algorithm-based denials reflects a broader fight over who controls cancer care decisions. - The policy fight also underscores a financial squeeze on independent oncology practices, which COA says can be forced to finance care while waiting for payment.

What's next: - Congress and Senate Finance staff can use the RFI comments to shape future health coverage legislation and oversight. - COA is likely to keep pressing for reforms tied to affordability, network protections, and faster payment for oncology care. - The organization’s full comment letter is available here.

The bottom line: - COA wants health coverage rules that let cancer patients start treatment on time, stay with their doctors, and avoid financial shock.